Varinder KaurDr Varinder Kaur MD, FACP has expertise in haematology and medical oncology, including clinical application of ibrutinib in its varied roles. She is a clinical trialist at University of Virginia, with particular focus on melanoma and head-neck cancer, immune-oncology, and vaccine trials. She has authored several high-quality publications including with rare side effects and resistance mechanisms for ibrutinib. She mentors clinical fellows and residents. She is a member of scientific review committee of Oncology Research Information Exchange Network and has reviewed grant applications for the same. She has served as a member for American Society of Clinical Oncology Systemic Therapy guidelines for melanoma committee and ASCO/ABIM test material development subcommittee, as well as a member of ASCO Education Book Review Panel. Read More Read Less